Ro 04-6790 is a drug, developed by Hoffmann–La Roche, which has applications in scientific research. It acts as a potent and selective receptor antagonist for the 5-HT6 serotonin receptor subtype, with little or no affinity at other receptors. In common with other drugs of this class,[1] Ro 04-6790 has nootropic effects in animals,[2] and reduces the amnesia produced by memory-impairing drugs such as dizocilpine[3] and scopolamine.[4]
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number |
|
PubChem CID |
|
IUPHAR/BPS |
|
ChemSpider |
|
ChEMBL |
|
Chemical and physical data | |
Formula | C12H16N6O2S |
Molar mass | 308.36 g·mol−1 |
3D model (JSmol) |
|
| |
| |
(verify) |